Pressure BioSciences, Inc. Stock
Stocks
PBIO
US74112E2081
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
21:55:42 20/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.000400 USD | -.--% |
|
-.--% | -20.00% |
| Market Cap | 143K 124K 116K 106K 199K 13.61M 200K 1.38M 535K 6.92M 538K 527K 22.95M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 19.8M 18.62M 16.96M 31.9M 2.18B 32.07M 220M 85.68M 1.11B 86.16M 84.29M 3.67B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 month | -42.86% | ||
| 3 months | -66.67% | ||
| 6 months | -20.00% | ||
| Current year | -20.00% |
| 1 month | 0 |  | 0.1 |
| Current year | 0 | | 0.1 |
| 1 year | 0 | | 0.2 |
| 3 years | 0 | | 0.8 |
| 5 years | 0 | | 2.85 |
| 10 years | 0 | | 13.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 16/04/2004 | |
| Chief Tech/Sci/R&D Officer | 61 | 03/04/2006 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 24/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 01/01/1992 | |
Jeffrey Peterson
CHM | Chairman | 70 | 08/08/2012 |
Michael Urdea
BRD | Director/Board Member | 73 | 08/02/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/27/24 A | Others | Chief Executive Officer | 22,878 | 0.0659% | ||
| 9/27/24 A | Others | Chairman | 59,652 | 0.1719% | ||
| 9/27/24 A | Others | Chief Technology Officer | 18,863 | 0.0543% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | +300.00% | -99.87% | 17.19K | |
| -2.69% | -4.40% | +21.87% | +7.77% | 222B | |
| -3.10% | -4.19% | +0.54% | -22.09% | 145B | |
| -2.02% | -0.70% | -21.98% | +18.96% | 130B | |
| -0.46% | -3.57% | -54.43% | -10.33% | 69.68B | |
| -0.01% | -0.14% | +11.56% | +18.80% | 52.3B | |
| -0.32% | -0.48% | -15.54% | -14.26% | 50.71B | |
| -2.36% | -3.13% | +19.31% | +22.98% | 42.28B | |
| -2.12% | -2.08% | +34.47% | +44.42% | 39.87B | |
| -3.64% | -2.21% | -15.72% | +45.34% | 33.37B | |
| Average | -1.38% | -5.39% | +28.01% | +1.17% | 78.62B | |
| Weighted average by Cap. | -1.63% | -1.58% | -0.31% | +6.08% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.49M 1.4M 1.28M 2.4M 164M 2.42M 16.59M 6.46M 83.49M 6.49M 6.35M 277M | 1.98M 1.71M 1.6M 1.46M 2.75M 188M 2.76M 18.97M 7.38M 95.48M 7.43M 7.26M 317M |
| Net income | -16.08M -13.87M -13.04M -11.88M -22.35M -1.53B -22.47M -154M -60.02M -776M -60.36M -59.05M -2.57B | -29.31M -25.29M -23.79M -21.67M -40.75M -2.78B -40.97M -281M -109M -1.42B -110M -108M -4.69B |
| Net Debt | 20.53M 17.71M 16.65M 15.17M 28.53M 1.95B 28.69M 197M 76.63M 991M 77.06M 75.39M 3.29B | 22.8M 19.67M 18.5M 16.86M 31.7M 2.16B 31.87M 219M 85.14M 1.1B 85.62M 83.76M 3.65B |
Employees
16
- Stock Market
- Stocks
- PBIO Stock
Select your edition
All financial news and data tailored to specific country editions
